Browsing “December, 2019 | EVERSANA”

The Netherlands to Set Lower Maximum Prices

Country: NETHERLANDS | Region: EUROPE | Type: Reference Pricing (IRP) | Keywords: #maximumdrugprices #medicinespricesact #ministryofmedicalcare #patentedmedicines #policy #regulation PRICENTRIC BRIEF: Since 1996, a maximum price for medicines in the Netherlands has been based on the average price in Germany, Belgium, France, and the United Kingdom; however, the Netherlands is swapping out Germany for Norway, where prices tend to be lower Bruno Bruins, Minister of Medical Care, said, […]

EVERSANA Sponsors DIA Pharmacovigilance and Risk Management Strategies Conference

Join EVERSANA at DIA’s Pharmacovigilance and Risk Management Strategies Conference, January 27-29, in Washington, DC. The conference will provide current thinking on predicting and assessing risks, assessment of expectedness of serious adverse reactions during clinical development, the complexities of assessing benefit-risk balance of today’s therapies (including immunotherapy and other advanced therapies), and impactful uses of […]

EVERSANA to Present at the 61st American Society of Hematology Annual Meeting & Exposition

EVERSANA proudly announces our participation at the 61st American Society of Hematology Annual Meeting & Exposition in Orlando, Florida. The ASH Annual Meeting is the world’s most comprehensive hematology event of the year and will provide an invaluable opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with […]